Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Acute confusion and delirium versus focal neurological disease

Neurology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

ABCDE instability, hypoglycaemia, sudden focal deficit, meningism, new seizure, severe headache, head injury, reduced consciousness, rapidly worsening agitation, inability to protect the airway or suspected encephalitis requires immediate treatment and senior emergency, stroke, neurological, infectious-disease or critical-care assessment; delirium is not a reason to defer these pathways.

Synopsis

Recognise delirium as an acute syndrome of impaired attention while actively identifying focal stroke, seizure, encephalitis and other neurological emergencies that can present through apparent confusion.

  • Delirium is an acute, usually fluctuating disturbance of attention and awareness with additional cognitive change. Hyperactive, hypoactive and mixed forms occur; quiet withdrawal is commonly missed.
  • Obtain baseline cognition, function and communication from someone who knows the patient, then establish hours-to-days onset, fluctuation and recent precipitant rather than accepting 'confused' as a diagnosis.
  • Use the 4AT or the locally mandated validated tool when delirium is suspected, but treat it as a structured assessment rather than a laboratory test that replaces clinical judgement.
  • Check glucose, oxygenation, ventilation, temperature, blood pressure, medication exposure, pain, urinary retention, constipation, hydration and withdrawal early because several triggers often coexist.
  • Aphasia can look like confusion: test naming, repetition, comprehension and fluency. Neglect can look inattentive, visual-field loss can look disoriented and apraxia can look uncooperative.
  • Sudden confusion with unilateral weakness, gaze deviation, visual loss, aphasia, neglect or severe imbalance should enter the stroke pathway even when a delirium trigger is also present.
  • Non-convulsive seizure may cause fluctuating responsiveness, speech arrest, automatisms, eye deviation or unexplained failure to recover; urgent EEG advice is warranted when the clinical pattern fits.
  • Fever, headache, personality change, focal deficit or seizure can signal encephalitis or meningitis. Empirical treatment must not wait for lumbar puncture when the procedure is delayed or unsafe.
  • Medication reconciliation includes new prescriptions, dose changes, anticholinergic burden, opioids, benzodiazepines, corticosteroids, dopaminergic drugs, over-the-counter products, alcohol and illicit substances.
  • Management begins with treating causes and providing orientation, hydration, sensory aids, sleep support, mobilisation and family involvement; restraint or sedation can worsen outcomes and needs exceptional justification.
  • Document attention, arousal, focal examination, collateral baseline, capacity for the specific decision and the plan to reassess. Delirium does not equal permanent incapacity.

Key red flags

Hypoactive delirium

Reduced movement, slow responses, sleepiness, poor intake and withdrawal with impaired attention may be mistaken for depression, fatigue or 'pleasant confusion'. It carries substantial risk and requires the same cause search as agitation.

Hyperactive delirium

Agitation, fear, hallucinations, sleep reversal and attempts to leave occur with fluctuating attention and disorganised thought. Pain, hypoxia, retention, withdrawal and an unfamiliar environment can all amplify behaviour.

Dominant-hemisphere stroke mimicry

Receptive or global aphasia can present as nonsensical answers, inability to follow instructions and apparent confusion. Sudden onset, paraphasia, naming or repetition impairment and lateralising signs support urgent stroke assessment.

Non-dominant parietal syndrome

Neglect, visuospatial disorientation, extinction, dressing difficulty and poor insight can appear as global cognitive disturbance. A lateralised attention deficit with abrupt onset is a focal cerebral syndrome.

Encephalitic syndrome

Subacute fever, headache, altered behaviour, memory disturbance, focal seizure or neurological deficit suggests brain inflammation. Normal initial imaging or absence of neck stiffness does not exclude encephalitis.

Non-convulsive status pattern

Persistent or fluctuating impaired awareness after a seizure, unexplained speech arrest, subtle twitching, automatisms or gaze deviation can reflect continuing electrical seizure despite no generalised convulsion.

Investigation priorities

01
4AT with collateral baseline and serial reviewFirst step

Identify altered alertness, impaired attention, acute change and fluctuation in a structured way.

Management branches

Acute global confusionConfirm delirium and treat causes

Hours-to-days cognitive change, impaired attention or fluctuating alertness without an immediately dominant focal syndrome.

  1. Perform ABCDE and glucose, obtain collateral baseline, use 4AT or the local validated assessment, and examine for focal neurology, meningism, trauma, pain, retention, constipation and dehydration.
  2. Investigate and treat plausible precipitants, rationalise medicines and withdrawal risk, and implement orientation, sensory aids, hydration, nutrition, sleep, mobilisation and familiar support.
  3. Review attention and arousal serially, escalate failure to improve or new focal signs, and communicate the syndrome, capacity implications and safety plan at every transition.

Key medicines

Short-term haloperidol in exceptional delirium-related distressIf non-drug de-escalation fails and the person remains distressed or dangerous, use the lowest clinically appropriate dose for the shortest possible time, ordinarily no longer than one week, under senior and local policy.Avoid or seek specialist advice in Parkinson's disease or Lewy-body dementia; assess QT prolongation, cardiovascular risk, electrolyte disturbance, extrapyramidal effects and interactions, particularly in frail older adults.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE CG103 delirium recommendationsNational guidance on risk, indicators, validated assessment, prevention and treatment.
  • NICE QS63 delirium quality standardQuality statements for recognising, documenting and managing delirium across care settings.
  • NICE NG128 stroke recommendationsUrgent assessment and imaging when apparent confusion contains sudden focal neurological features.
  • MHRA haloperidol delirium safety reminderUK safety advice on cautious short-term use, contraindications and cardiac and neurological adverse effects.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom